WINNERS & LOSERS: Metlen Energy takes hit from annual results delay

Fri, 27th Mar 2026 10:30

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

----------

FTSE 100 winners

----------

3i Group PLC, up 3.5% at 2,381.50 pence, after outlining 2026 guidance on Thursday

AstraZeneca PLC, up 3.4% at 14,293.00p, hails positive lung disease trial results

Relx PLC, up 1.4% at 2,432.00p

Experian PLC, up 1.1% at 2,573.00p

NatWest Group PLC, up 0.7% at 538.60p, as Deutsche Bank raises target to 840p from 730p

----------

FTSE 100 losers

----------

Metlen Energy & Metals PLC, down 5.9% at EUR32.70, delay of publication of annual results

Barratt Redrow PLC, down 2.8% at 260.80p

Games Workshop Group PLC, down 2.4% at 17,775.00p

Segro PLC, down 2.3% at 637.00p

Persimmon PLC, down 2.2% at 1093.25p

----------

FTSE 250 winners

----------

Playtech PLC, up 6.0% at 333.50p, launches GBP19 million share buyback

Mony Group PLC, up 3.7% at 154.00p, as Jefferies upgrades to 'buy' with 230p target

Pollen Street Group PLC, up 2.0% at 822.00p, as Berenberg raises target to 1,100p

RTW Biotech Opportunities Ltd, up 2.6% at USD1.99

Schroder Oriental Income Fund Ltd, up 1.0% at 365.75p

----------

FTSE 250 losers

----------

Ceres Power Holdings PLC, down 10% at 296.40 pence, pares Thursday's 6.7% gain after Centrica deal

Harbour Energy PLC, down 5.3% at 284.10p, as BASF cuts stake to 35% after upsized placing

Goodwin PLC, down 4.6% at 12,550.00p

SDCL Energy Efficiency Income Trust PLC, down 3.8% at 39.80p

Aston Martin Lagonda Global Holdings PLC, down 3.5% at 36.39p

----------

FTSE 100 & 250 movers in focus:

----------

AstraZeneca PLC, up 3.4% at 14,293.00 pence, 12-month range 9,573.50p-15,732.00p. Reports positive phase three results for its chronic obstructive pulmonary disease [COPD] treatment tozorakimab. Says the drug delivers "significant and highly clinically meaningful" reductions in exacerbations in two replicate trials, Oberon and Titania. Tozorakimab, a monoclonal antibody targeting interleukin-33, aims to reduce inflammation and disrupt mucus dysfunction linked to disease worsening. Patients received 300mg doses every four weeks, with the trials focusing on those still experiencing symptoms despite standard inhaled treatments.

----------

Metlen Energy & Metals PLC, down 5.9% at EUR32.70, 12-month range EUR30.50-EUR57.73. Athens-based energy and metallurgy company - Says auditors PricewaterhouseCoopers LLP and PricewaterhouseCoopers SA have requested more time to complete work on its 2025 financial statements, its first as a dual-listed company in London and Athens. The group now expects to release results on April 9, a nine-day delay, and reiterates guidance for earnings before interest, tax, depreciation and amortisation of around GBP750 million.

----------

Harbour Energy PLC, down 5.3% at 284.10 pence, 12-month range 146.40p-382.20p. Falls after BASF SE cuts its stake to 35% from 41.5% via an accelerated placing. BASF sells 80 million shares at 273p each, raising around GBP218.4 million, with the deal upsized from 60 million shares on strong demand. The stake reduction follows BASF's acquisition of shares through the Wintershall Dea asset transfer. Separetly, Goldman Sachs raises its price target to 250p from 230p, reiterating a 'sell' rating.

----------

Playtech PLC, up 6.0% at 333.50p, 12-month range 210.00p-814.00p.- Starts on Friday share buyback programme for up to 5.7 million shares, worth about GBP19.0 million at their current market price. Playtech plans to complete the buyback before its next annual general meeting, set to be held towards the end of May. The buyback will be run by US investment bank Jefferies International Ltd. The repurchased shares will be used for future employee share awards.

----------

GB Group PLC, up 0.8% at 194.60 pence, 12-month range 187.80p-314.00p. Says it has successfully refinanced its revolving credit facility, securing a new GBP175 million unsecured RCF maturing in September 2030, replacing its previous secured facility due in July 2027. The Chester, England-based identity and location technology provider says the new facility, which includes two optional one-year extension options, has been arranged with a syndicate of existing and new lenders.

----------

By Eva Castanedo, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Risers and Fallers Market News